TR201908150T4 - Peptitler ve kullanımları. - Google Patents

Peptitler ve kullanımları. Download PDF

Info

Publication number
TR201908150T4
TR201908150T4 TR2019/08150T TR201908150T TR201908150T4 TR 201908150 T4 TR201908150 T4 TR 201908150T4 TR 2019/08150 T TR2019/08150 T TR 2019/08150T TR 201908150 T TR201908150 T TR 201908150T TR 201908150 T4 TR201908150 T4 TR 201908150T4
Authority
TR
Turkey
Prior art keywords
spp
peptides
peptide
infections
amino acids
Prior art date
Application number
TR2019/08150T
Other languages
English (en)
Turkish (tr)
Inventor
O'neil Deborah
Mercer Derry
Charrier Cedric
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2010/000631 external-priority patent/WO2010112848A2/en
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Publication of TR201908150T4 publication Critical patent/TR201908150T4/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
TR2019/08150T 2010-03-31 2011-03-30 Peptitler ve kullanımları. TR201908150T4 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2010/000631 WO2010112848A2 (en) 2009-03-31 2010-03-31 Inhibition of biofilm organisms
US39008110P 2010-10-05 2010-10-05
GBGB1016733.6A GB201016733D0 (en) 2010-10-05 2010-10-05 Compounds and their use

Publications (1)

Publication Number Publication Date
TR201908150T4 true TR201908150T4 (tr) 2019-06-21

Family

ID=43243521

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/08150T TR201908150T4 (tr) 2010-03-31 2011-03-30 Peptitler ve kullanımları.

Country Status (29)

Country Link
US (1) US8901071B2 (cg-RX-API-DMAC7.html)
EP (3) EP3479824A3 (cg-RX-API-DMAC7.html)
JP (1) JP5969457B2 (cg-RX-API-DMAC7.html)
KR (1) KR101922409B1 (cg-RX-API-DMAC7.html)
CN (1) CN102906105B (cg-RX-API-DMAC7.html)
AU (3) AU2011234252B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012024676B1 (cg-RX-API-DMAC7.html)
CA (1) CA2797437C (cg-RX-API-DMAC7.html)
CY (1) CY1121658T1 (cg-RX-API-DMAC7.html)
DK (1) DK2552434T3 (cg-RX-API-DMAC7.html)
ES (1) ES2729313T3 (cg-RX-API-DMAC7.html)
GB (1) GB201016733D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20190982T1 (cg-RX-API-DMAC7.html)
HU (1) HUE044549T2 (cg-RX-API-DMAC7.html)
IL (1) IL222027A (cg-RX-API-DMAC7.html)
LT (1) LT2552434T (cg-RX-API-DMAC7.html)
MX (1) MX2012011369A (cg-RX-API-DMAC7.html)
NZ (2) NZ603200A (cg-RX-API-DMAC7.html)
PL (1) PL2552434T3 (cg-RX-API-DMAC7.html)
PT (1) PT2552434T (cg-RX-API-DMAC7.html)
RS (1) RS58980B1 (cg-RX-API-DMAC7.html)
RU (1) RU2590706C2 (cg-RX-API-DMAC7.html)
SG (1) SG184138A1 (cg-RX-API-DMAC7.html)
SI (1) SI2552434T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900365T1 (cg-RX-API-DMAC7.html)
TR (1) TR201908150T4 (cg-RX-API-DMAC7.html)
UA (1) UA118167C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011121289A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201208173B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201501646PA (en) * 2012-09-07 2015-04-29 Agency Science Tech & Res Peptides and their uses
US20150119345A1 (en) * 2013-10-29 2015-04-30 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of gastrointestinal infections
GB2522412A (en) * 2014-01-22 2015-07-29 Agency Science Tech & Res Antimicrobial peptidomimetics
DE102014101663A1 (de) * 2014-02-11 2015-08-13 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Synthetische artifizielle Peptide mit antimikrobieller Wirkung
GB2524777A (en) * 2014-04-02 2015-10-07 Microarray Ltd Dressing comprising electrodes
WO2016054091A1 (en) * 2014-09-29 2016-04-07 The Research Foundation For The State University Of New York Compositions and methods for reducing cutaneous microbiome malodor
KR101781679B1 (ko) * 2014-11-21 2017-09-26 한양대학교 산학협력단 수 처리 물질 및 그 제조 방법
WO2017134661A1 (en) * 2016-02-04 2017-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
CN110114075B (zh) 2016-11-09 2024-01-12 俄亥俄州国家创新基金会 含有二硫化物的细胞穿透肽及其制备和使用方法
US11352394B2 (en) 2016-11-22 2022-06-07 Ohio State Innovation Foundation Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
AU2018227569A1 (en) * 2017-03-03 2019-09-26 Peptilogics, Inc. Engineered antimicrobial amphiphilic peptides and methods of use
WO2019023617A1 (en) * 2017-07-27 2019-01-31 University Of Utah Research Foundation DEVICE FOR DELIVERY OF THERAPEUTIC PRODUCT
WO2019070962A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation BICYCLIC PEPTIDE INHIBITORS
US11865181B2 (en) * 2017-11-03 2024-01-09 Yale University Peptidic materials that traffic efficiently to the cell cytosol and nucleus
US11793884B2 (en) 2018-01-29 2023-10-24 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of CAL-PDZ binding domain
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
CN110227144A (zh) * 2019-06-12 2019-09-13 华懿思科(成都)生物科技有限公司 一种消除妇科炎症致病菌及hpv病毒的抗菌肽靶向制剂及其制备方法
EP4100070A4 (en) * 2020-02-09 2024-03-06 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. ANTIMICROBIAL MATRIX AND USES THEREOF FOR ELIMINATING MICROORGANISMS
CN111533781B (zh) * 2020-03-30 2022-02-08 东北农业大学 非特异受体结合型真菌靶向抗菌肽及其制备方法和应用
US20230287061A1 (en) * 2020-08-10 2023-09-14 Università Cattolica del Sacro Cuore New antimicrobial peptides
CN112586785B (zh) * 2020-12-03 2022-02-08 青岛大学附属医院 一种驴鞭食用胶原蛋白肽-明胶复合胶囊壁材制备方法
RU2771493C1 (ru) * 2021-04-15 2022-05-05 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Пептид, обладающий антибактериальной активностью в отношении микроорганизмов с множественной лекарственной устойчивостью
CA3221235A1 (en) * 2021-06-11 2022-12-15 Ali Ladram Short antimicrobial peptides
CN116606347B (zh) * 2023-04-28 2024-03-29 东北农业大学 一种抗菌肽frrffp及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3561444A (en) 1968-05-22 1971-02-09 Bio Logics Inc Ultrasonic drug nebulizer
US3703173A (en) 1970-12-31 1972-11-21 Ted A Dixon Nebulizer and tent assembly
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
US4635627A (en) 1984-09-13 1987-01-13 Riker Laboratories, Inc. Apparatus and method
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
DK0752885T3 (da) 1992-09-25 2003-11-03 Neorx Corp Terapeutisk inhibitor for celler i den glatte karmuskulatur
GB2408263A (en) * 2003-11-14 2005-05-25 Pacgen Biopharmaceuticals Inc Antimicrobial peptides with reduced hemolysis and methods of their use.
PT1778720E (pt) 2004-08-18 2010-11-29 Novabiotics Ltd Péptidos antimicrobianos compreendendo um motivo com arginina e/ou lisina
KR20070086065A (ko) * 2004-11-12 2007-08-27 노보자임스 에이/에스 항균성을 가진 폴리펩티드 및 그것을 코딩하는폴리뉴클레오티드
US20070093894A1 (en) * 2005-10-25 2007-04-26 Baylor College Of Medicine Incorporation of antimicrobial combinations onto devices to reduce infection
CN100467481C (zh) * 2006-04-18 2009-03-11 河北师范大学 棕点湍蛙抗菌多肽及其在制药中的应用
CN101070341A (zh) * 2006-05-08 2007-11-14 徐永强 无致突变作用的抗菌多肽
PL2061886T3 (pl) * 2006-08-21 2014-10-31 Univ British Columbia Małe kationowe peptydy immunomodulujące
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
CN101168564B (zh) * 2007-10-22 2012-03-21 中国科学院昆明动物研究所 人源性抗菌肽及其衍生物的用途
EP2168590A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms

Also Published As

Publication number Publication date
MX2012011369A (es) 2012-11-30
RU2590706C2 (ru) 2016-07-10
AU2011234252A1 (en) 2012-11-22
AU2011234252B2 (en) 2016-05-12
ES2729313T3 (es) 2019-10-31
EP2552434B1 (en) 2019-05-08
RS58980B1 (sr) 2019-08-30
SG184138A1 (en) 2012-10-30
WO2011121289A3 (en) 2012-03-15
HRP20190982T1 (hr) 2019-10-18
PT2552434T (pt) 2019-06-12
SI2552434T1 (sl) 2019-08-30
LT2552434T (lt) 2019-07-25
CN102906105A (zh) 2013-01-30
CA2797437C (en) 2017-11-07
EP3578193A3 (en) 2020-05-20
NZ603200A (en) 2014-02-28
AU2016208308A1 (en) 2016-08-11
CY1121658T1 (el) 2020-07-31
KR101922409B1 (ko) 2018-11-27
AU2018202201A1 (en) 2018-04-26
CA2797437A1 (en) 2011-10-06
EP3578193A2 (en) 2019-12-11
ZA201208173B (en) 2013-07-31
EP2552434A2 (en) 2013-02-06
EP3479824A3 (en) 2019-08-14
US20130102524A1 (en) 2013-04-25
JP5969457B2 (ja) 2016-08-17
RU2012145756A (ru) 2014-05-10
SMT201900365T1 (it) 2019-07-11
EP2552434B9 (en) 2019-09-11
EP3479824A2 (en) 2019-05-08
AU2016208308B2 (en) 2018-01-18
UA118167C2 (uk) 2018-12-10
PL2552434T3 (pl) 2019-09-30
WO2011121289A2 (en) 2011-10-06
AU2018202201B2 (en) 2019-12-05
HUE044549T2 (hu) 2019-11-28
EP3578193C0 (en) 2023-09-06
BR112012024676A2 (pt) 2016-06-07
IL222027A (en) 2016-11-30
US8901071B2 (en) 2014-12-02
NZ618571A (en) 2015-02-27
DK2552434T3 (da) 2019-06-11
EP3578193B1 (en) 2023-09-06
BR112012024676B1 (pt) 2022-05-03
GB201016733D0 (en) 2010-11-17
KR20130043625A (ko) 2013-04-30
JP2013523703A (ja) 2013-06-17
CN102906105B (zh) 2017-05-10

Similar Documents

Publication Publication Date Title
EP2552434B9 (en) Peptides and their use
US7847059B2 (en) Methods for treatment of a dermatophytic fungal infection
AU2011235933B2 (en) Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
HK1187357A (en) Antimicrobial peptides comprising an arginine- and/or lysine-containing motif